PREDICTING A PML-RARA FUSION GENE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA BY CONVOLUTIONAL NEURAL NETWORKS

EHA Library, Chia-Jen Liu, 266629

IS QUERCETIN ABLE TO REVERT THE APOPTOTIC RESISTANCE TRIGGERED BY THE SHORT ISOFORM OF GATA-1 IN MYELOID LEUKEMIA CELLS?

EHA Library, Silvia trombetti, 266630

GLYCOLYSIS VERSUS OXIDATIVE PHOSPHORYLATION - POTENTIAL THERAPEUTIC TARGETS IN AML

EHA Library, Ana Bela Sarmento-Ribeiro, 266631

SINGLE-CELL RNA-SEQUENCING & GENOTYPING OF PATIENTS WITH WT1-SUBCLONAL AML TO ELUCIDATE CLONAL HETEROGENEITY

EHA Library, Julia Niggemeyer, 266632

COMPARATIVE ANALYSES OF LEUKEMIC BLAST PHENOTYPE AND MUTANT/WT EXPRESSION RATIO IN FLT3-ITD ACUTE MYELOID LEUKEMIAS

EHA Library, Dan Soare, 266633

MICRO RNA SIGNATURE OF ONCOGENIC MUSASHI RNA BINDING PROTEINS MSI1 AND MSI2

EHA Library, Sujitha Duggimpudi, 266634

TUMOR IMMUNE ESCAPE MEDIATED BY TH17CCR4-CCR6+ CELLS AND IL-6/IL-10/IL-17A IN ACUTE MYELOID LEUKEMIA

EHA Library, Amaya Zabalza, 266635

HIGH CYTOMEGALOVIRUS VIRUS LOAD INDUCES A POTENT TUMOR-SPECIFIC CD8+ T CELL RESPONSE AND PROTECTS PATIENT IN ACUTE MYELOID LEUKEMIA FROM RELAPSE AFTER SINGLE CORD BLOOD TRANSPLANTATION

EHA Library, Zimin Sun, 266636

SNP ARRAY REVEALS A NEW DELETION OF JAK2 IN AML PATIENTS

EHA Library, Claudio Cerchione, 266637

GOOD SENSITIVITY OF ACUTE MYELOID LEUKEMIAS INVOLVING ONLY GRANULOCYTE-MONOCYTE LINE (GM-AML) TO STANDARD-DOSE INDUCTION THERAPY (SICT) IS NOT INFLUENCED BY AGE

EHA Library, Petr Lemez, 266638

PREFERENTIAL TRANSCRIPTION OF THE MUTATED ALLELE IN NPM1 MUTATED ACUTE MYELOID LEUKAEMIA

EHA Library, Graham Bailey, 266639

MUTANT IDH1 INHIBITOR IVOSIDENIB (AG-120) IN COMBINATION WITH AZACITIDINE FOR NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, Courtney D. DiNardo, 266640

IMPACT OF MINIMAL RESIDUAL DISEASE AND COMPLETE REMISSION (CR)/CR WITH PARTIAL HEMATOLOGIC RECOVERY ON SURVIVAL AFTER GILTERITINIB THERAPY IN PATIENTS WITH FLT3-MUTATED RELAPSED/REFRACTORY AML

EHA Library, Mark Levis, 266641

IVOSIDENIB (AG-120) INDUCES DURABLE REMISSIONS AND TRANSFUSION INDEPENDENCE IN PATIENTS WITH IDH1-MUTANT NEWLY-DIAGNOSED AML: UPDATED RESULTS FROM A PHASE 1 DOSE ESCALATION AND EXPANSION STUDY

EHA Library, Gail J. Roboz, 266642

ENASIDENIB ASSOCIATED WITH IMPROVED SURVIVAL COMPARED WITH STANDARD OF CARE FOR R/R AML PATIENTS WITH AN IDH2 MUTATION BASED ON DATA FROM STUDY AG221-C-001 AND A REVIEW OF PATIENT CHARTS IN FRANCE

EHA Library, Stephane DE BOTTON, 266643

ASSESSMENT OF MOLECULAR MRD KINETICS BY ERROR-CORRECTED NEXT-GENERATION SEQUENCING PROVIDES INDEPENDENT PROGNOSTIC INFORMATION IN ADULT AML PATIENTS

EHA Library, Tracy Murphy, 266644

ALLG APML5: A COMPARATIVE BIOAVAILABILITY STUDY OF ENCAPSULATED ORAL ARSENIC TRIOXIDE AND INTRAVENOUS ARSENIC TRIOXIDE IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA UNDERGOING CONSOLIDATION THERAPY

EHA Library, Harry J Iland, 266645

CLINICAL BENEFIT OF GLASDEGIB PLUS LOW-DOSE CYTARABINE IN PATIENTS WITH DE NOVO AND SECONDARY ACUTE MYELOID LEUKEMIA: LONG-TERM ANALYSIS OF A PHASE 2 RANDOMIZED TRIAL

EHA Library, Walter Fiedler, 266646

COMPLETE REMISSION WITH INCOMPLETE BLOOD COUNT RECOVERY IS A STRONG PREDICTOR OF NON-RELAPSE MORTALITY IN ACUTE MYELOID LEUKEMIA PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Ivetta Danylesko, 266647

DECITABINE VERSUS INTENSIVE CHEMOTHERAPY IN ELDERLY UNTREATED ACUTE MYELOID LEUKEMIA

EHA Library, Adolfo De La Fuente, 266648

SURVIVAL FROM ACUTE MYELOID LEUKEMIA HAS SINCE 1997 IMPROVED ONLY IN MALES AGED 50-75 YEARS - A SWEDISH POPULATION-BASED STUDY

EHA Library, Gunnar JULIUSSON, 266649

A PROOF OF CONCEPT OF LSD1-INHIBITON IN A PHASE I/II PILOT TRIAL OF TCP AND ATRA IN REFRACTORY / RELAPSED AML PATIENTS NOT ELIGIBLE FOR INTENSIVE THERAPY

EHA Library, Maxi Wass, 266650

PHASE I DOSE ESCALATION CLINICAL TRIAL OF H3B-8800, A SPLICING MODULATOR, IN PATIENTS WITH ADVANCED MYELOID MALIGNANCIES

EHA Library, David Steensma, 266651

GEMTUZUMAB OZOGAMICINE-BASED SALVAGE THERAPIES IN REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Sonia Jaramillo Segura, 266652

UPDATED RESULTS FROM A PHASE 1 STUDY OF GILTERITINIB IN COMBINATION WITH INDUCTION AND CONSOLIDATION CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED AML

EHA Library, Alexander Perl, 266653

FINAL REPORT: CLINICAL STUDY OF ORAL ARSENIC TRIOXIDE CAPSULE FORMULATION, ORH-2014, DEMONSTRATING HIGH BIOAVAILABILITY, GOOD SAFETY AND TOLERABILITY IN PATIENTS WITH ADVANCED HEMATOLOGIC DISORDERS

EHA Library, Farhad Ravandi-Kashani, 266654

FLT3 TESTING IN THE RYDAPT ERA

EHA Library, Stuart Scott, 266655

ROBUST IDENTIFICATION OF CLINICALLY RELEVANT MUTATIONS IN AML USING RNA-SEQ

EHA Library, Muxin Gu, 266656

DETECTION OF MRD MAY PREDICT THE OUTCOME OF PATIENTS WITH ACUTE MYELOID LEUKEMIA WITH BIALLELIC CEBPA MUTATIONS

EHA Library, Jing Wang, 266657

TREATMENT PATTERNS AND OUTCOMES IN PATIENTS WITH IDH2-MUTATED RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA - A FRENCH MEDICAL CHART REVIEW ANALYSIS

EHA Library, Arnaud Pigneux, 266658

ISOCITRATE DEHYDROGENASE 1/2 MUTATIONS AND ASSOCIATIONS IN ACUTE MYELOID LEUKEMIA

EHA Library, Petra Kovy, 266659

OUTCOMES OF PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA: A POPULATION-BASED REAL-WORLD STUDY

EHA Library, Joseph M. Brandwein, 266660

THE PROGNOSTIC SIGNIFICANCE OF BCR-1 AND BCR-3 ISOFORM OF PML-RARA AND FLT3-ITD IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Mosaad El Gammal, 266661

INDIRECT NUMBER NEEDED TO TREAT: COMPARATIVE EFFECTIVENESS OF GLASDEGIB + LOW-DOSE CYTARABINE VS AZACITIDINE OR DECITABINE IN ACUTE MYELOID LEUKEMIA PATIENTS INELIGIBLE FOR INTENSIVE CHEMOTHERAPY

EHA Library, Anna Forsythe, 266662

FLT3 LIGAND PLASMA LEVELS HAVE NO IMPACT ON OUTCOMES AFTER ALLOTRANSPLANT IN ACUTE LEUKEMIA.

EHA Library, Pierre Peterlin, 266663

EFFICACY AND SAFETY EVALUATION OF DIFFERENT DOSES OF ANTHRACYCLINES IN THE INDUCTION THERAPY FOR NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Xiaohui Hu, 266664

BASELINE SERUM LEVELS OF RECEPTORS FOR INTERLEUKIN-2 AND TUMOR NECROSIS FACTOR-Α PREDICT OVERALL SURVIVAL IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, Tomas Kupsa, 266665

COMPARATIVE RANDOMIZED STUDY OF PROTOCOL HAM VERSUS PROTOCOL FLAG IN RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Alyaa elsergany, 266666

MARKER CHROMOSOME IS A STRONG POOR PROGNOSIS FACTOR AFTER ALLOGENEIC HSCT FOR AML PATIENTS

EHA Library, Kyok Fuse, 266667

FT-2102, AN IDH1M INHIBITOR, INDUCES MUTATION CLEARANCE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) OR MYELODYSPLASTIC SYNDROME (MDS) TREATED IN PHASE 1 DOSE ESCALATION AND EXPANSION STUDY

EHA Library, Stephane DE BOTTON, 266668

AGE >70 YEARS, HIGH-RISK CYTOGENETICS, SORROR COMORBIDITY SCORE >1 AND BLAST COUNT>40% IN BM ARE RISK FACTORS FOR INDUCTION FAILURE OF STANDARD CHEMOTHERAPY WITH ANTHRACYCLINE AND CYTARABINE IN AML

EHA Library, Ahmet ELMAAGACLI, 266669

IMPACT OF CYTOMEGALOVIRUS REACTIVATION ON RELAPSE RATE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOBLASTIC LEUKEMIA

EHA Library, Nour Ben Adejlil, 266670

INTENSIFIED CONDITIONING WITH FLUDARABINE/MELPHALAN PLUS TOTAL BODY IRRADIATION VERSUS FLUDARABINE/MELPHALAN ALONE FOR ACUTE MYELOID LEUKEMIA

EHA Library, Sarah Lindner, 266671

NEGATIVE MINIMAL RESIDUAL DISEASE STATUS BY MULTICOLOUR FLOW CYTOMETRY AFTER 1ST COURSE IS THE MOST PREDICTIVE FACTOR FOR AML PATIENTS

EHA Library, Tatiana Lobanova, 266672

ACUTE MYELOID LEUKEMIA OR MYELODYSPLASTIC SYNDROME WITH CHROMOSOME 17 ABNORMALITIES AND LONG-TERM OUTCOMES WITH OR WITHOUT HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Ghulam Rehman Mohyuddin, 266673

INDUCTION WITH FLUGA SCHEME AND MAINTENANCE WITH DECITABINE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA OF 65 YEARS AND OLDER

EHA Library, Sofia Belen COSTA, 266674

NOVEL CIRCULATING TUMOR DNA (CTDNA) BASED DDPCR DROP-OFF ASSAYS FOR IMPROVED DISEASE MONITORING IN ACUTE MYELOID LEUKEMIA (AML) A “LIQUID BIOPSY” FOR A “LIQUID TUMOR”

EHA Library, Christian Rausch, 266675

DEFINING TRANSIENT ABNORMAL MYELOPOIESIS BY GATA1 MUTATION IN INFANTS WITH DOWN SYNDROME

EHA Library, Iman Ragab, 266676

CO-OCCURRENCE OF DNMT3A-R882, FLT3 AND NPM1 MUTATIONS IDENTIFIES A SUBSET OF AML PATIENTS WITH ADVERSE PROGNOSIS

EHA Library, Matheus F Bezerra, 266677

ELDERLY PATIENTS WITH DE NOVO OR SECONDARY AML HAVE COMPARABLE OUTCOMES AFTER INTENSIVE TREATMENTS INCLUDING HIGH DOSE (HD) CYTARABINE AND AUTOLOGOUS (AUTO) OR ALLOGENEIC (ALLO) TRANSPLANTATION (SCT)

EHA Library, massimo bernardi, 266678

PEDIATRIC ACUTE MYELOID LEUKEMIA (AML) IN DEVELOPING COUNTRIES, BARRIERS AGAINST BETTER OUTCOME 10 YEARS’ EXPERIENCE AMONG EGYPTIAN PEDIATRIC ACUTE MYELOID LEUKEMIA

EHA Library, Youssef Madney, 266679

RESULTS OF PIVOTAL PHASE 2 CLINICAL TRIAL OF TAGRAXOFUSP (SL-401) IN PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN)

EHA Library, Naveen Pemmaraju, 266680

EXPLORATORY ANALYSIS OF OUTCOMES WITH SEQUENTIAL FLT3-INHIBITOR (FLT3I) BASED THERAPIES IN RELAPSED FLT3-MUTATED AML PATIENTS (PTS)

EHA Library, Masnour Alfayez, 266681

OPEN-LABEL STUDY OF GILTERITINIB, GILTERITINIB PLUS AZACITIDINE, OR AZACITIDINE ALONE IN NEWLY DIAGNOSED FLT3-MUTATED AML PATIENTS INELIGIBLE FOR INTENSIVE CHEMOTHERAPY: RESULTS FROM THE SAFETY COHORT

EHA Library, Jordi Esteve, 266682

AXICABTAGENE CILOLEUCEL (AXI-CEL) IN REFRACTORY LARGE B CELL LYMPHOMA: OUTCOMES IN PATIENTS ≥ OR < 65 YEARS OF AGE IN THE PIVOTAL PHASE 1/2 ZUMA-1 STUDY

EHA Library, Sattva S. Neelapu, 266683

AXICABTAGENE CILOLEUCEL (AXI-CEL) IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B CELL LYMPHOMA: PRELIMINARY RESULTS OF EARLIER STEROID USE

EHA Library, Max S. Topp, 266684

SAFETY ANALYSIS OF AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP NHL29: A PHASE II STUDY OF IBRUTINIB, RITUXIMAB AND MINI-CHOP IN VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B CELL LYMPHOMA

EHA Library, Emma Verner, 266685

THE ECHELON-2 TRIAL: RESULTS OF A RANDOMIZED, DOUBLE-BLIND PHASE 3 STUDY OF BRENTUXIMAB VEDOTIN AND CHP (A+CHP) VERSUS CHOP IN FRONTLINE TREATMENT OF PATIENTS WITH CD30+ PERIPHERAL T-CELL LYMPHOMAS

EHA Library, Tim Illidge, 266687

SURVIVAL OF B-CELL LYMPHOMAS IN THE PRE- AND POST-RITUXIMAB ERAS: 30 YEARS REAL-WORLD DATA

EHA Library, Mohamed Gouda, 266689

PRELIMINARY RESULTS OF ASTX660, A NOVEL NON-PEPTIDOMIMETIC CIAP1/2 AND XIAP ANTAGONIST, IN RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA AND CUTANEOUS T CELL LYMPHOMA

EHA Library, Amitkumar Mehta, 266690

SANDOZ RITUXIMAB FOR THE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA: INTERIM SAFETY RESULTS OF THE PROSPECTIVE NON-INTERVENTIONAL, OBSERVATIONAL, MULTICENTER, OPEN-LABEL REFLECT STUDY

EHA Library, Manfred Welslau, 266691

ANTITUMOR ACTIVITY OF PEMBROLIZUMAB PLUS DINACICLIB IN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA: THE PHASE 1B KEYNOTE-155 STUDY

EHA Library, Gareth Gregory, 266692

PROGNOSTIC IMPACT OF BCL2 AND MYC EXPRESSION AND TRANSLOCATION AMONG NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS TREATED WITH R-CHOP IN THE REAL WORLD

EHA Library, MK Downer, 266693

EVENT FREE SURVIVAL AT 12 MONTHS AND 24 MONTHS AS PREDICTORS FOR OUTCOME OF SYSTEMIC PERIPHERAL T CELL LYMPHOMA: ANALYSIS OF NATIONWIDE THAI LYMPHOMA STUDY GROUP

EHA Library, Kitsada Wudhikarn, 266694

A PHASE II STUDY OF FRACTIONATED CYCLOPHOSPHAMIDE, VINBLASTINE, ORAL ETOPOSIDE AND PREDNISOLONE IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME RELATED LYMPHOMAS

EHA Library, Hasmukh Jain, 266695

CLINICAL OUTCOME OF INTENSIFIED CHEMO-TARGETED THERAPY IN ACTIVATED B CELL NON HODGKIN LYMPHOMA

EHA Library, Ahmed Sohaib, 266696

LYMPHOMA ASSOCIATED HEMOPHAGOCYTIC SYNDROME: A SINGLE-CENTER EXPERIENCE.

EHA Library, Javier Alberto Rojas Martínez, 266697

UTILITY OF BONE MARROW BIOPSY IN POSITRON EMISSION TOMOGRAPHY-STAGED PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Mark Grech, 266698

PROGNOSTIC SIGNIFICANCE OF SAMHD1 EXPRESSION IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

EHA Library, Ioanna Xagoraris, 266699

EFFICACY AND TOXICITY OF INTENSIVE CHEMOTHERAPY REGIMENS IN PRIMARY MEDIASTINAL (THYMIC) LARGE В-CELL LYMPHOMA.

EHA Library, Inga Zavodnova, 266700

AUTOLOGOUS STEM CELL TRANSPLANT IN DIFFUSE LARGE B CELL LYMPHOMA: SIMILAR OUTCOMES AFTER BEAM AND FEAM CONDITIONING REGIMENS

EHA Library, Bruno Loureiro, 266701

ORAL CHOP LIKE CHEMOTHERAPY IN ELDERLY PATIENTS WITH HIGH-GRADE NON HODGKIN B CELL LYMPHOMA

EHA Library, Stephanie Guidez, 266702

THE INCIDENCE AND CLINICAL IMPACT OF RHOA G17V MUTATION IN ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA PATIENTS

EHA Library, Ya-Ting Hsu, 266703

ESHAP VERSUS GEMOX IN MANAGEMENT OF RELAPSED OR REFRACTORY LYMPHOMA: A PROSPECTIVE RANDOMIZED STUDY

EHA Library, Rasha Salama, 266704

A RETROSPECTIVE COHORT STUDY TO EVALUATE THE OUTCOMES OF HIV-ASSOCIATED HIGH-GRADE B-CELL NON-HODGKIN LYMPHOMA (NHL) TREATED WITH DOSE ADJUSTED R EPOCH REGIMEN

EHA Library, Jayshree Thorat, 266705

PET-SCAN FOR RESPONSE ASSESSEMENT AFTER RITUXIMAB-DOSE-ADJUSTED-EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): CLINICAL AND PROGNOSTIC SIGNIFICANCE

EHA Library, Theodoros Vassilakopoulos, 266706

OBINUTUZUMAB DOES NOT COMPROMISE MOBILIZATION AND ENGRAFTMENT OF AUTOLOGOUS PERIPHERAL BLOOD STEM CELLS IN LYMPHOMA PATIENTS: RESULTS FROM A FIL PROSPECTIVE PHASE II STUDY (THE GIOTTO STUDY)

EHA Library, Roberta BATTISTINI, 266707

TREATMENT OF ACTIVATED B-CELL LYMPHOMA WITH RITUXIMAB,DOXORUBICIN,ETOPOSIDE,PREDNISOLONE/IFOSFAMIDE+CISPLATIN PLUS LENALIDOMIDE (R-ACEP/ICL), CONFERS LONG PROGRESSION FREE AND OVERALL SURVIVAL RATES

EHA Library, Maher Salamoon, 266708

TANDEM AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR TREATMENT OF ADULT T-CELL LYMPHOBLASTIC LYMPHOMA: A MULTIPLE CENTER PROSPECTIVE STUDY IN SOUTHWESTERN CHINA

EHA Library, Cheng ZHANG, 266709

IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED DLBCL, CHANGE WEIGHT AFTER THE FIRST COURSE R-CHOP (-LIKE) CHEMOTHERAPY IS AN ADVERSE PROGNOSTIC FACTOR

EHA Library, Ayako Muramatsu, 266710

MANAGING CYTOKINE RELEASE SYNDROME (CRS) AND NEUROTOXICITY WITH STEP-FRACTIONATED DOSING OF MOSUNETUZUMAB IN RELAPSED/REFRACTORY (R/R) B-CELL NON-HODGKIN LYMPHOMA (NHL)

EHA Library, Sung-Soo Yoon, 266711

RAPID INFUSION WITH CT-P10 IN PATIENTS WITH NON-HODGKIN’S LYMPHOMA OR CHRONIC LYMPHOCYTIC LEUKAEMIA: INTERIM RESULTS FROM A EUROPEAN NON-INTERVENTIONAL POST-AUTHORISATION SAFETY STUDY

EHA Library, Mark J Bishton, 266712

INTERIM UPDATE FROM A MULTI-CENTER STUDY OF PRALATREXATE IN ASIAN PATIENTS WITH RELAPSED OR REFRACTORY(R/R) PERIPHERAL T-CELL LYMPHOMA (PTCL)

EHA Library, Ming-Chung Wang, 266713

ADULT T-CELL LEUKEMIA/LYMPHOMA : EPIDEMIOLOGY, CLINICAL FEATURES AND OUTCOME OF A CARIBBEAN COHORT FROM GUADELOUPE

EHA Library, Philippe HELIAS, 266714

ADULT ONSET HEREDITARY THROMBOTIC THROMBOCYTOPENIC PURPURA WITH A NOVEL ADAMTS13 MUTATION

EHA Library, Julian Matias Freue, 266715

CONGENITAL FACTOR V DEFICIENCY FROM COMPOUND HETEROZYGOUS MUTATIONS WITH A NOVEL MUTATION C.2426DEL (P.PRO809HISFS*2) IN THE F5 GENE

EHA Library, Chang-Hun Park, 266717

PERIOPERATIVE MANAGEMENT AND OUTCOMES IN CHILDREN WITH CONGENITAL BLEEDING DISORDERS: A RETROSPECTIVE REVIEW AT A SINGLE HEMOPHILIA TREATMENT CENTER

EHA Library, Young Shil Park, 266718

HEMOPHILIA ASSOCIATED BONE PATHOLOGY IMPACTS QUALITY OF LIFE

EHA Library, Galen Goldscheitter, 266719

NOVEL COMPOUND HETEROZYGOUS MUTATIONS CAUSING FACTOR XI DEFICIENCY IN UNRELATED TWO CHINESE PATIENTS

EHA Library, Qian Li, 266720

EPIDEMIOLOGICAL STUDY OF IDIOPATHIC THROMBOCYTOPENIC PURPURA AMONG THE ADULT POPULATION OF THE RUSSIAN FEDERATION

EHA Library, Anait Melikyan, 266721

CONGENITAL DEFICIENCY OF COAGULATION FACTOR VII IN THE SOUTH OF TUNISIA: ABOUT 88 CASES.

EHA Library, Safouan Kacem, 266722

A RETROSPECTIVE ANALYSIS OF IMMUNE THROMBOCYTOPENIA PATIENTS TREATMENT RESULTS AFTER SEQUENTIAL SWITCHING OF THROMBOPOIETIC RECEPTOR-AGONISTS

EHA Library, Maria Pankrashkina, 266723

IMPACT OF SEVERITY OF THE DISEASE AND FVIII INHIBITOR ON BONE MINERAL DENSITY AND BONE TURNOVER MARKER IN CHILDREN WITH HEMOPHILIA A

EHA Library, Panagiota Xafaki, 266724

CLINICAL FEATURES AND TREATMENT OUTCOMES OF ACQUIRED HEMOPHILIA A IN KOREA: RETROSPECTIVE ANALYSIS.

EHA Library, K S Lee, 266725

DENTAL HEALTH STATUS IN PATIENTS WITH HEMOPHILIA. SINGLE CENTER EXPERIENCE IN ROMANIA.

EHA Library, Cristina Emilia Ursu, 266726

THE IDENTIFICATION OF A COMMON LOSS-OF-FUNCTION MUTATION ACROSS DIFFERENT HLA CLASS ALLELES FREQUENTLY DETECTED IN PATIENTS WITH ACQUIRED APLASTIC ANEMIA

EHA Library, Hiroki Mizumaki, 266727

QUANTIFICATION OF METABOLITES IN DRIED BLOOD SPOTS OF DIAMOND BLACKFAN ANEMIA PATIENTS REVEALS NOVEL INSIGHTS IN DEREGULATED CELLULAR PATHWAYS INVOLVED IN HYPOPLASTIC ANEMIA.

EHA Library, Birgit van Dooijeweert, 266728

OLIGOCLONALITY OF T-CELL RECEPTOR AND THE MAIN SUBPOPULATION COMPOSITION IN PATIENTS WITH APLASTIC ANEMIA AT DIFFERENT STAGES OF THE DISEASE.

EHA Library, Anastasia Abramova, 266730

PATIENTS WITH GAUCHER DISEASE SHOW AN IMMUNE-DYSREGULATION PATTERN SECONDARY TO A DEFECT OF APOPTOSIS

EHA Library, Maurizio Miano, 266731

THE RELATIONSHIP BETWEEN THE PRETREATMENT PNH CLONE SIZE AND CLINICAL COURSE IN PATIENTS WITH BONE MARROW FAILURE SYNDROMES: INTERIM ANALYSIS OF JAPANESE MULTICENTER PROSPECTIVE STUDY

EHA Library, Yasutaka Ueda, 266732